When these amino acids oxidize, the peptide structure changes in ways that can reduce receptor binding affinity
Low blood sugar: In patients with type 2 diabetes, semaglutide can cause low blood sugar levels (hypoglycemia) when used in combination with other diabetes medications
Emerging research suggests that GLP-1RAs may also be beneficial in treating conditions like obstructive sleep apnea (Malhotra et al., 2024), osteoarthritis (Bliddal et al., 2024), metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis with liver fibrosis (MASH) (Loomba et al., 2024), polycystic ovary syndrome (PCOS) (Szczesnowicz et al., 2023), Alzheimers disease (Liang et al., 2024), Parkinsons disease (Kalinderi et al., 2024), and addiction (Klausen et al., 2022)
Margarete Moen On Jul 23, 2026, Verified: Mrs